SCHEMBL9348174

SCHEMBL9348174

O=c1c(CCCCO)c(O)c2cccnc2n1-c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 4/20 0.42
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
ALDH1A1 P00352 3/20 0.42
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
THRB P10828 2/20 0.41
FEN1 P39748 1/20 0.39
EP300 Q09472 1/20 0.39
CREBBP Q92793 1/20 0.39
KAT2A Q92830 1/20 0.39
KAT2B Q92831 1/20 0.39
GAA P10253 1/20 0.39
PDE4A P27815 2/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348332 0.97 MAPT (0.45) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL10377542 0.90 MAPT (0.44) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL9352380 0.90 ALDH1A1 (0.46) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL9348282 0.90 FEN1 (0.50) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL9348283 0.89 MAPT (0.46) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL9348372 0.89 FEN1 (0.49) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL10379180 0.88 KAT2B (0.42) MAPTKDM4EALDH1A1L3MBTL1EP300
SCHEMBL9352348 0.86 ALDH1A1 (0.47) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL9352330 0.86 FEN1 (0.51) MAPTHPGDKDM4ECYP1A2CYP3A4
SCHEMBL10667933 0.86 PKM (0.47) MAPTKDM4ECYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350755-A Treatment of psoriasis or eczema with naphthyridine derivative SCHERING CORPORATION (US) 1994-09-27 US disclosed
EP-0144996-B1 SUBSTITUTED SPIRO PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1990-02-28 EP disclosed
US-4775524-A PSORIASIS SCHERING CORPORATION (US) 1988-10-04 US disclosed
US-4652564-A Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents SCHERING CORPORATION (US) 1987-03-24 US disclosed
US-4632923-A Substituted hetero spiro pyridine derivatives as anti-allergy and anti-inflammatory agents SCHERING CORPORATION (US) 1986-12-30 US disclosed
EP-0144996-A2 Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions SCHERING CORPORATION (US) 1985-06-19 EP disclosed